Frances M Cowan1, Calum B Davey, Elizabeth Fearon, Phillis Mushati, Jeffrey Dirawo, Valentina Cambiano, Sue Napierala Mavedzenge, Dagmar Hanisch, Ramona Wong-Gruenwald, Milton Chemhuru, Nyasha Masuka, Karin Hatzold, Owen Mugurungi, Joanna Busza, Andrew N Philips, James R Hargreaves. 1. *Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; †Centre for Sexual Health & HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe; ‡Department of Social and Environmental Health Research, Centre for Evaluation, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; §Women's Global Health Imperative, RTI International, San Francisco, CA; ‖United Nations Population Fund, Harare, Zimbabwe; ¶Gesellschaft für Internationale Zusammenarbeit, Harare, Zimbabwe; #Midlands Province, Ministry of Health and Child Welfare, Harare, Zimbabwe; **Matebeleland North Province, Ministry of Health and Child Welfare, Harare, Zimbabwe; ††Population Services International Global, Harare, Zimbabwe; ‡‡HIV AIDS TB Unit, Ministry of Health and Child Welfare, Harare, Zimbabwe; and §§Department of Population Studies, Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Abstract
INTRODUCTION: Female sex workers (FSW) in sub-Saharan Africa have a higher prevalence of HIV than other women of reproductive age. Social, legal, and structural barriers influence their access to care. Little is known about the HIV diagnosis and care cascade in most countries in Southern Africa. We aimed to describe the HIV diagnosis and care cascade among FSW in Zimbabwe. METHODS: We conducted cross-sectional respondent driven sampling (RDS) surveys of FSW in 14 sites across Zimbabwe as the baseline for a cluster-randomised controlled trial investigating a combination HIV prevention and care package. We administered a questionnaire, tested women for HIV and measured viral load. We report the mean, minimum, and maximum respondent-driven sampling-2 weighted site values. RESULTS: The survey included 2722 women, approximately 200 per site. The mean HIV prevalence was 57.5% (42.8-79.2 site minimum and maximum). Of HIV-positive women, 64.0% (51.6-73.7) were aware of their status, 67.7% (53.4-84.1) of these reported taking antiretroviral therapy, and 77.8% (64.4-90.8) of these had a suppressed HIV viral load (<1000 copies/mL). Among all HIV-positive women, 49.5% had a viral load < 1000 copies/mL. CONCLUSIONS: Although most HIV-positive women aware of their status are accessing antiretroviral therapy, 36.0% of HIV-positive women are unaware of their status and 29.3% of all FSW have an unsuppressed HIV viral load. Investigation and investment into models of testing, treatment, and care are necessary to reach UNAIDS targets for HIV elimination.
INTRODUCTION: Female sex workers (FSW) in sub-Saharan Africa have a higher prevalence of HIV than other women of reproductive age. Social, legal, and structural barriers influence their access to care. Little is known about the HIV diagnosis and care cascade in most countries in Southern Africa. We aimed to describe the HIV diagnosis and care cascade among FSW in Zimbabwe. METHODS: We conducted cross-sectional respondent driven sampling (RDS) surveys of FSW in 14 sites across Zimbabwe as the baseline for a cluster-randomised controlled trial investigating a combination HIV prevention and care package. We administered a questionnaire, tested women for HIV and measured viral load. We report the mean, minimum, and maximum respondent-driven sampling-2 weighted site values. RESULTS: The survey included 2722 women, approximately 200 per site. The mean HIV prevalence was 57.5% (42.8-79.2 site minimum and maximum). Of HIV-positive women, 64.0% (51.6-73.7) were aware of their status, 67.7% (53.4-84.1) of these reported taking antiretroviral therapy, and 77.8% (64.4-90.8) of these had a suppressed HIV viral load (<1000 copies/mL). Among all HIV-positive women, 49.5% had a viral load < 1000 copies/mL. CONCLUSIONS: Although most HIV-positive women aware of their status are accessing antiretroviral therapy, 36.0% of HIV-positive women are unaware of their status and 29.3% of all FSW have an unsuppressed HIV viral load. Investigation and investment into models of testing, treatment, and care are necessary to reach UNAIDS targets for HIV elimination.
Authors: Sue Napierala; Sungai T Chabata; Calum Davey; Elizabeth Fearon; Joanna Busza; Phillis Mushati; Owen Mugurungi; Karin Hatzold; Valentina Cambiano; Andrew Phillips; James R Hargreaves; Frances M Cowan Journal: PLoS One Date: 2022-06-28 Impact factor: 3.752
Authors: Mucho Mizinduko; Kåre Moen; Britt Pinkowski Tersbøl; Samuel L Likindikoki; Mwijage Alexander Ishungisa; Germana H Leyna; Neema Makyao; Melkizedeck T Leshabari; Angela Ramadhani; Dan Wolf Meyrowitsch; Theis Lange; Elia J Mmbaga Journal: AIDS Care Date: 2021-12-18
Authors: Kate Shannon; Anna-Louise Crago; Stefan D Baral; Linda-Gail Bekker; Deanna Kerrigan; Michele R Decker; Tonia Poteat; Andrea L Wirtz; Brian Weir; Marie-Claude Boily; Jenny Butler; Steffanie A Strathdee; Chris Beyrer Journal: Lancet Date: 2018-07-20 Impact factor: 79.321
Authors: Sunil S Solomon; Allison M McFall; Gregory M Lucas; Aylur K Srikrishnan; Muniratnam S Kumar; Santhanam Anand; Thomas C Quinn; David D Celentano; Shruti H Mehta Journal: PLoS Med Date: 2017-11-28 Impact factor: 11.069
Authors: Katrina Ortblad; Daniel Kibuuka Musoke; Thomson Ngabirano; Aidah Nakitende; Jonathan Magoola; Prossy Kayiira; Geoffrey Taasi; Leah G Barresi; Jessica E Haberer; Margaret A McConnell; Catherine E Oldenburg; Till Bärnighausen Journal: PLoS Med Date: 2017-11-28 Impact factor: 11.069
Authors: Michael M Chanda; Katrina F Ortblad; Magdalene Mwale; Steven Chongo; Catherine Kanchele; Nyambe Kamungoma; Andrew Fullem; Caitlin Dunn; Leah G Barresi; Guy Harling; Till Bärnighausen; Catherine E Oldenburg Journal: PLoS Med Date: 2017-11-21 Impact factor: 11.069
Authors: Bernadette Hensen; James R Hargreaves; Tarisai Chiyaka; Sungai Chabata; Phillis Mushati; Sian Floyd; Isolde Birdthistle; Joanna Busza; Frances Cowan Journal: BMC Public Health Date: 2018-01-31 Impact factor: 3.295